Valens Clinical service
Ketamine care
A structured, clinician-supervised pathway for eligible adults, with medical and mental-health review, preparation, monitoring and follow-up integration.
Individualized care
Start with your concerns and goals
Valens begins with a clinical review rather than a preset treatment package. The first visit determines whether this pathway, another Valens service or outside specialty care is the safest next step.
- Adults with treatment-resistant symptoms seeking specialist review
- Patients referred for a supervised ketamine eligibility assessment
- People able to arrange transportation and comply with recovery restrictions
- Adults whose diagnosis, medical risk and support setting permit outpatient care
Scope of care
Services available within this pathway
Availability and recommendations depend on clinical findings, clinician scope, facility readiness and applicable requirements.
Medical and psychiatric eligibility assessment
Preparation and transportation planning
Clinician-supervised administration when approved
Physiologic and psychological monitoring
Discharge, integration and longitudinal follow-up
Clinical evaluation
What the team reviews
Relevant records are reviewed before repeating testing whenever practical.
- Current diagnosis, symptom severity and immediate safety
- Prior medication, psychotherapy and procedural treatment response
- Psychosis, mania, substance-use and dissociation history
- Blood pressure, cardiovascular, respiratory and neurologic risk
- Pregnancy, bladder and medication considerations
- Responsible-adult transportation and recovery environment
What to expect
A clear path from intake to follow-up
- 1Complete confidential medical and mental-health screening
- 2Meet with the qualified clinician for eligibility review
- 3Discuss evidence, off-label status when applicable, risks and alternatives
- 4Complete separate treatment-specific informed consent
- 5Receive monitored treatment only if approved
- 6Follow driving restrictions, discharge guidance and clinical follow-up
Safety and follow-up
Monitoring is part of treatment
Plans are adjusted using response, tolerance, objective findings and patient goals. New symptoms or adverse effects may require pausing treatment or referral.
Blood pressure, pulse, oxygenation and protocol observations
Sedation, dissociation, anxiety, nausea and emergence symptoms
Mood, suicidality, pain or target-symptom response
Misuse risk, urinary symptoms and cognitive concerns
Transportation, recovery and post-treatment safety
Connected specialty resource
KetamineHubs
The connected KetamineHubs resource provides additional eligibility education and access information.
Common questions
Before you begin
Is ketamine FDA-approved for depression?
Ketamine itself is FDA-approved as an anesthetic, not for psychiatric disorders. Use for depression is off-label. Intranasal esketamine has specific FDA-approved psychiatric indications and separate requirements.
Can ketamine be used at home through Valens?
This page describes clinician-supervised care. At-home compounded ketamine has additional safety concerns because onsite monitoring is absent.
Can I drive after treatment?
No. Patients must follow the clinician’s restriction and arrange responsible transportation. Treatment-day driving and other hazardous activities are prohibited.
Does ketamine replace therapy or ongoing psychiatric care?
No. When used, it should be part of a broader plan that addresses diagnosis, standard treatments, safety, psychotherapy or psychiatric follow-up as appropriate.
Patient education
Trusted resources
These independent resources provide general education and do not replace an individualized consultation.
Next step
Begin with a secure clinical intake
Do not send medical details through ordinary email. Use the portal so the authorized clinical team can review your request.